GSA Capital Partners LLP Buys New Holdings in Omada Health, Inc. $OMDA

GSA Capital Partners LLP bought a new position in Omada Health, Inc. (NASDAQ:OMDA) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 58,714 shares of the company’s stock, valued at approximately $1,289,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Raymond James Financial Inc. bought a new stake in Omada Health in the 2nd quarter valued at $32,000. Bellevue Group AG boosted its position in shares of Omada Health by 0.7% during the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after acquiring an additional 1,791 shares in the last quarter. Quarry LP bought a new stake in Omada Health in the fourth quarter valued at about $29,000. Barclays PLC increased its stake in Omada Health by 14.6% in the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock valued at $234,000 after acquiring an additional 1,888 shares during the period. Finally, TD Waterhouse Canada Inc. acquired a new position in Omada Health in the fourth quarter worth about $32,000.

Omada Health Stock Down 1.2%

Shares of OMDA stock opened at $23.75 on Tuesday. Omada Health, Inc. has a 12-month low of $10.28 and a 12-month high of $26.92. The company has a market capitalization of $1.45 billion, a P/E ratio of 475.00 and a beta of 1.73. The firm has a 50-day moving average price of $21.10 and a 200 day moving average price of $16.54.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings results on Thursday, August 6th. The company reported $0.08 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.10. The firm had revenue of $87.83 million for the quarter, compared to analyst estimates of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, research analysts expect that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OMDA has been the topic of a number of recent research reports. Wells Fargo & Company lifted their price objective on Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. BTIG Research increased their target price on Omada Health from $30.00 to $35.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Citizens Jmp raised their target price on Omada Health from $27.00 to $32.00 and gave the stock a “market outperform” rating in a research report on Friday. The Goldman Sachs Group restated a “buy” rating on shares of Omada Health in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. boosted their price target on Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a research note on Friday. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $26.50.

Insider Buying and Selling

In related news, CEO Sean P. Duffy sold 25,886 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $22.68, for a total transaction of $587,094.48. Following the completion of the sale, the chief executive officer directly owned 411,861 shares of the company’s stock, valued at $9,341,007.48. This trade represents a 5.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Steven L. Cook sold 33,000 shares of Omada Health stock in a transaction on Friday, June 26th. The shares were sold at an average price of $19.89, for a total value of $656,370.00. Following the completion of the transaction, the chief financial officer owned 133,359 shares of the company’s stock, valued at approximately $2,652,510.51. The trade was a 19.84% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 254,726 shares of company stock valued at $5,370,496 in the last quarter. 6.38% of the stock is currently owned by corporate insiders.

Omada Health Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.